Home Salipro Biotech

Salipro Biotech

In operation
-
Pharmaceutical R&D Developer
Basic
Enterprise Profile

Basic Information

Salipro Biotech Develops Nanoparticles to Increase the Solubility of Hydrophobic Substances.Unlocking challenging drug targets for the development of next-generation therapies, most drug targets are so-called membrane proteins, which are inherently unstable and difficult to study. Our proprietary Salipro® technology stabilizes membrane proteins in their native form, enabling their use in drug discovery for therapeutic antibodies or small molecule drugs, thereby driving the discovery of new medicines.
Salipro Biotech AB
Stockholm,Stockholm,Sweden
less than 15 people
January 01, 2016
--

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Biotechnology
Concept
Tumor Therapeutic Products
Application Scenarios
Innovative Drugs Nanotechnology